As filed with the Securities and Exchange Commission on June 25, 2004.
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 25, 2004 (June 24, 2004)
MEDAREX, INC.
(Exact name of registrant as specified in its charter)
|
New Jersey |
|
0-19312 |
|
22-2822175 |
|
(State of other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
|
|
|
|
|
707 State Road, Princeton, N.J. 08540-1437 |
||||
|
(Address of Principal Executive Offices) |
||||
|
|
||||
|
Registrant’s telephone number, including area code: (609) 430-2880 |
||||
|
|
||||
|
Not Applicable |
||||
|
(Former name or former address, if changed since last report) |
||||
MEDAREX, INC.
TABLE OF CONTENTS
FOR
CURRENT REPORT ON FORM 8-K
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
2
Item 5. Other Events
On June 25, 2004, the Company announced that it had entered into an agreement to acquire all of the issued and outstanding shares of capital stock of Ability Biomedical Corporation, a Canadian biotechnology company. A copy of the Company’s press release dated June 25, 2004, relating to the acquisition is attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
|
Exhibit |
|
|
|
|
|
|
|
99.1 |
|
Press Release issued June 25, 2004 |
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MEDAREX, INC. |
||
|
|
Registrant |
||
|
|
|
||
|
|
|
||
|
Date: June 25, 2004 |
By: |
/s/ Donald L. Drakeman |
|
|
|
Donald L. Drakeman |
||
|
|
President
and Chief |
||
4
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
Page |
|
|
|
|
|
|
|
99.1 |
|
Press Release issued June 25, 2004 |
|
|
5